Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

Generating music with AI! (MusicLM Explained)

(Sponsor) Take this survey and you can win new gear and help the Developer community (and mine): https://www.developereconomics.net/?member_id=whatsai&utm_medium=youtube.

References:
►Read the full article: https://www.louisbouchard.ai/musiclm/
►Agostinelli et al., 2023: MusicLM, https://arxiv.org/pdf/2301.11325.pdf.
►Listen to more results: https://google-research.github.io/seanet/musiclm/examples/
►My Newsletter: https://www.louisbouchard.ai/newsletter/
►Support me on Patreon: https://www.patreon.com/whatsai.
►Join Our Discord community, Learn AI Together: https://discord.gg/learnaitogether.

#ai #artificialintelligence #MusicLM

What The?! How is This Able to Fly?

For additional information watch:
Magnetohydrodynamic (MHD) Propulsion — What Is It?

Credits:

Special thanks to all our patrons and volunteers!
Thank you for your support!

Blender.
For all their hard work in making an amazing and.
professional program.

Scientists all over the Globe For providing much scientific data.
and working hard to give all of us a bright and amazing future.

Music:

ChatGPT Passed Exams From Graduate Business and Law Schools

ChatGPT, the artificial intelligence tool that has been used in everything from high school essays to a speech on the floor of Congress, has added another accomplishment to its résumé: passing exams from law and business schools.

The AI tool was presented with several tests from both the University of Minnesota’s law school and the University of Pennsylvania’s Wharton School of Business, passing them all.

That said, the AI didn’t necessarily ace the exams with flying colors. The chatbot answered 95 multiple choice questions and 12 essay prompts across 4 of UM’s law school tests, averaging about a C+ performance overall. The tech did better in Wharton’s business management course exam, scoring between a B to B-.

How Our Brains Turn Into Smarter Disease Fighters

CRISPR gene editing created the G795A amino acid which was introduced to microglia derived from human stem cells. Researchers were able to transplant the donor microglia immune cells into humanized rodent models while administering an FDA-approved cancer drug called pexidartinib. The inclusion of the amino acid cause the donated microglia to thrive and resist the drug, while the host microglia died. The findings open the door for new methods of using microglia to treat a range of neurodegenerative disorders.